Financial News Feed

PHOENIX, May 13, 2019 /PRNewswire/ -- Aethlon Medical Inc. (AEMD) and its diagnostic subsidiary, Exosome Sciences, in collaboration with the Translational Genomics Research Institute (TGen) and the Prostate On-Site Project (POP), announced that Aethlon, TGen and POP will engage with participants for...

Read more

Aethlon files for $5M mixed shelf
12:10am, Sunday, 12'th May 2019
No summary available....

Read more

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 15) Amneal Pharmaceuticals Inc (NYSE: AMRX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN )(the company is said to explore a potential sale ) Medtronic PLC (NYSE: MDT ) Vermillion, Inc. (NASDAQ: VRML ) Down In The Dumps (Biotech stocks hitting 52-week lows on April 15) Achaogen Inc (NASDAQ: AKAO )(announced bankruptcy filing) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aethlon Medical, Inc. (NASDAQ: AEMD ) Assembly Biosciences Inc (NASDAQ: ASMB )(presented interim mid-stage results of its hepatitis B virus treatment candidate ABI-H0731) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Conatus Pharmaceuticals Inc (NASDAQ: CNAT )(announced Phase 2 clinical trial evaluating emricasan in NASH patients with cirrhosis and severe portal hypertension) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Imv Inc (NASDAQ: IMV ) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Vaxart Inc (NASDAQ: VXRT ) Verastem Inc (NASDAQ: VSTM ) See Also: The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Stock In Focus Motif Says New Iclaprim Data Shows Comparable Efficacy With Standard-of-care MOTIF BIO PLC/S ADR (NASDAQ: MTFB ) presented additional data for iclaprim at the 28th European Congress of Clinical Microbiology and Infectious Diseases, which showed it had comparable efficacy to vancomycin in treating acute bacterial skin and skin structure infection, or ABSSSI, lesions....

Read more

The stock of Aethlon Medical, Inc. (NASDAQ:AEMD) hit a new 52-week low and has $0.84 target or 4.00 % below today’s $0.88 share price. The 6 months bearish chart indicates high risk for the $16.69M ...

Read more

Los Angeles, United State, April 1, 2019– The research study offers powerful guidelines for market players to compete well against other participants operating in the global Medical Membrane Devices...

Read more

Aethlon Medical (NASDAQ:AEMD) and Illumina (NASDAQ:ILMN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, val...

Read more

The trend-following momentum indicator that illustrates the relationship between two moving averages is called the Moving Average Convergence Divergence. MACD can be found by subtracting the 26-day ex...

Read more

Investors may be interested in following the opinion signal on shares of Aethlon Medical (AEMD). For the current trading period, we can see that the opinion signal on the stock is 80% Sell. Heading ba...

Read more

Wall Street analysts predict that Aethlon Medical, Inc. (NASDAQ:AEMD) will report sales of $300,000.00 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for ...

Read more

Illumina (NASDAQ:ILMN) and Aethlon Medical (NASDAQ:AEMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommenda...

Read more

Aethlon Medical (NASDAQ:AEMD) and Illumina (NASDAQ:ILMN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommenda...

Read more

Shares of Aethlon Medical (AEMD) have been tilting lower over the past 13 weeks, revealing bearish momentum for the shares, as they have dipped -26.52% over the past quarter. Looking further out we no...

Read more

Analysts expect Moelis & Company (NYSE:MC) to report $0.70 EPS on April, 22.They anticipate $0.05 EPS change or 7.69% from last quarter’s $0.65 EPS. MC’s profit would be $41.02 million giving it 1...

Read more

Traders following current indicator levels on shares of Aethlon Medical (AEMD) can note that the short-term MACD indicator is presently reading a Sell. The MACD is typically used to measure bullish or...

Read more

Brokerages forecast that Aethlon Medical, Inc. (NASDAQ:AEMD) will post ($0.08) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimat...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank